Stopping GLP-1 Drugs Raises Heart Risk for Diabetics
Stopping GLP-1 Drugs Raises Heart Risk for Diabetics
Stopping GLP-1 Drugs Raises Heart Risk for Diabetics
Key points
اہم نکات
मुख्य बातें
- People with type 2 diabetes who stop taking GLP-1 weight-loss drugs face a sharply higher risk of heart attack, stroke and death, a new study has found.
- Researchers tracked more than 80,000 patients at 301 diabetes clinics in Italy and found those who stopped the drugs were about twice as likely to suffer a heart attack, a non-fatal stroke or to die as those who kept taking them, and more than four times as likely to die from any cause.
- The authors say long-term use may be needed to keep the heart protection the drugs offer, and warn the risk rises the longer treatment is stopped.
- People with type 2 diabetes who stop taking GLP-1 weight-loss drugs face a sharply higher risk of heart attack, stroke and death, a new study has found.
- Researchers tracked more than 80,000 patients at 301 diabetes clinics in Italy and found those who stopped the drugs were about twice as likely to suffer a heart attack, a non-fatal stroke or to die as those who kept taking them, and more than four times as likely to die from any cause.
- The authors say long-term use may be needed to keep the heart protection the drugs offer, and warn the risk rises the longer treatment is stopped.
- People with type 2 diabetes who stop taking GLP-1 weight-loss drugs face a sharply higher risk of heart attack, stroke and death, a new study has found.
- Researchers tracked more than 80,000 patients at 301 diabetes clinics in Italy and found those who stopped the drugs were about twice as likely to suffer a heart attack, a non-fatal stroke or to die as those who kept taking them, and more than four times as likely to die from any cause.
- The authors say long-term use may be needed to keep the heart protection the drugs offer, and warn the risk rises the longer treatment is stopped.
People with type 2 diabetes who stop taking GLP-1 weight-loss drugs face a sharply higher risk of heart attack, stroke and death, a new study has found. Researchers tracked more than 80,000 patients at 301 diabetes clinics in Italy and found those who stopped the drugs were about twice as likely to suffer a heart attack, a non-fatal stroke or to die as those who kept taking them, and more than four times as likely to die from any cause. The authors say long-term use may be needed to keep the heart protection the drugs offer, and warn the risk rises the longer treatment is stopped. The study is observational, so it shows a link rather than proof that stopping the drug itself causes the extra risk.
People with type 2 diabetes who stop taking GLP-1 weight-loss drugs face a sharply higher risk of heart attack, stroke and death, a new study has found. Researchers tracked more than 80,000 patients at 301 diabetes clinics in Italy and found those who stopped the drugs were about twice as likely to suffer a heart attack, a non-fatal stroke or to die as those who kept taking them, and more than four times as likely to die from any cause. The authors say long-term use may be needed to keep the heart protection the drugs offer, and warn the risk rises the longer treatment is stopped. The study is observational, so it shows a link rather than proof that stopping the drug itself causes the extra risk.
People with type 2 diabetes who stop taking GLP-1 weight-loss drugs face a sharply higher risk of heart attack, stroke and death, a new study has found. Researchers tracked more than 80,000 patients at 301 diabetes clinics in Italy and found those who stopped the drugs were about twice as likely to suffer a heart attack, a non-fatal stroke or to die as those who kept taking them, and more than four times as likely to die from any cause. The authors say long-term use may be needed to keep the heart protection the drugs offer, and warn the risk rises the longer treatment is stopped. The study is observational, so it shows a link rather than proof that stopping the drug itself causes the extra risk.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।